On 19 January Intrexon Corporation has announced, together with ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) the signing of an exclusive licensing agreement with The University of Texas MD Anderson Cancer Center for the development of non-viral adoptive cellular cancer immunotherapies. On Thursday shares of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) closed at $9.08.
Kate Spade & Company (NYSE:KATE) announced strategic initiatives that will further focus its business on the long-term growth of the kate spade new york brand. As part of this announcement, Kate Spade & Company is absorbing key elements of Kate Spade Saturday’s success into kate spade new york and discontinuing Kate Spade Saturday as a standalone business. Kate Spade & Company (NYSE:KATE) in last trading activity increased 6.56% to close at $31.68. Company weekly performance is 12.86% while its quarterly performance stands at 18.12%. Kate Spade & Company (NYSE:KATE) is -26.10% away from its 52 week high.
Exlservice Holdings, Inc. (NASDAQ:EXLS) will announce financial results for its fourth quarter and full year ended December 31, 2014 on Tuesday, February 24, 2015 before the market opens, and will hold a conference call that morning at 8:00 a.m. (ET) to discuss the Company’s operating and financial results. On last trading day Exlservice Holdings, Inc. (NASDAQ:EXLS) increased 1.65% to close at $30.76. Its volatility for the week is 2.52% while volatility for the month is 2.88%. EXLS’s sales growth for past 5 years was 21.40% and its EPS growth for past 5 years was 30.20%. Exlservice Holdings, Inc. (NASDAQ:EXLS) monthly performance is 5.70%.
On 13 January, Empresas ICA, S.A.B. de C.V. (NYSE:ICA) announced the signing of the public works contract to build the Santa Maria reservoir dam with the Federal Water Commission, Conagua. The Ps. 3,989 million unit-price, fixed-term public works contract was awarded through a domestic bidding process. The project is scheduled to be completed in January 2018. Empresas ICA, S.A.B. de C.V. (NYSE:ICA) has 0.03% insider ownership while its institutional ownership stands at 10.60%. In last trading activity company’s stock closed at $4.07.
Zacks upgraded shares of Etablissements Delhaize Freres et Cie Le Lion (NYSE:DEG) from a neutral rating to an outperform rating in a research report released on Tuesday morning. Zacks currently has $19.70 price objective on the stock. On last trading day Etablissements Delhaize Freres et Cie Le Lion (NYSE:DEG) increased 1.44% to close at $21.11. Its volatility for the week is 1.58% while volatility for the month is 1.38%. DEG’s sales growth for past 5 years was 2.10% and its EPS growth for past 5 years was 13.50%. Etablissements Delhaize Freres et Cie Le Lion (NYSE:DEG) monthly performance is 14.85%.